3-Bromo-2-pyrazinamine(CAS: 21943-12-4)

3-Bromo-2-pyrazinamine (CAS: 21943-12-4) falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes classification for health hazards, environmental hazards, and flammability. Additionally, it is regulated by the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) in the European Union, requiring manufacturers and importers to register substances above a certain tonnage threshold. In the United States, it must comply with the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) for safety and regulatory compliance.

In the synthesis of 3-Bromo-2-pyrazinamine (CAS: 21943-12-4), alternative reagents such as 3-chloro-2-pyrazinamine or 2-chloro-3-pyrazinamine can be used as bromine analogs. Other common alternatives include various pyrimidines and imidazoles, which can serve similar functional groups. These alternatives are often chosen based on availability, cost, and specific reaction conditions.

The market for 3-Bromo-2-pyrazinamine (CAS: 21943-12-4) is primarily driven by its use in pharmaceuticals and research applications. Recent trends indicate a growing interest in its use as an intermediate in the synthesis of anti-inflammatory and antimicrobial agents. Research is also exploring its potential in cancer treatment. Market trends suggest a steady demand, with increasing emphasis on sustainable and environmentally friendly synthesis methods.

Waste containing 3-Bromo-2-pyrazinamine (CAS: 21943-12-4) should be collected in appropriate, leak-proof containers and stored away from heat and ignition sources. For disposal, it is recommended to consult the Material Safety Data Sheet (MSDS) and local regulations. Common disposal methods include incineration or professional waste disposal services that comply with environmental protection laws. Proper training and personal protective equipment (PPE) should be used during handling and disposal to ensure safety.